News
PepsiCo (PEP) Dips More Than Broader Market: What You Should Know
PepsiCo (PEP) closed the most recent trading day at $160.80, moving -1.9% from the previous trading session. This change lagged the S&P 500's 0.57% loss on the day. Meanwhile, the Dow experienced a
Robinhood Markets, Inc. (HOOD) Declines More Than Market: Some Information for Investors
Robinhood Markets, Inc. (HOOD) ended the recent trading session at $80.56, demonstrating a -2.01% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily
Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors
Johnson & Johnson (JNJ) closed at $239.63 in the latest trading session, marking a -2.31% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.57%. Elsewhere
Microsoft (MSFT) Gains As Market Dips: What You Should Know
Microsoft (MSFT) ended the recent trading session at $410.68, demonstrating a +1.35% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 0.57%
NextEra Energy (NEE) Dips More Than Broader Market: What You Should Know
NextEra Energy (NEE) closed at $91.13 in the latest trading session, marking a -1.59% move from the prior day. This move lagged the S&P 500's daily loss of 0.57%. Meanwhile, the Dow lost 1.61%, and
Meta Platforms (META) Falls More Steeply Than Broader Market: What Investors Need to Know
Meta Platforms (META) closed at $660.41 in the latest trading session, marking a -1.1% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.57%. Meanwhile, the Dow
Bit Digital, Inc. (BTBT) Declines More Than Market: Some Information for Investors
Bit Digital, Inc. (BTBT) closed the most recent trading day at $1.72, moving -7.53% from the previous trading session. This move lagged the S&P 500's daily loss of 0.57%. Elsewhere, the Dow lost
BJ's Wholesale Is Growing, Buying Back Stock, and Still Dirt Cheap
BJ’s Wholesale Club (NYSE: BJ) is a quality buy in 2026 because it is growing, outperforming guidance, has a healthy balance sheet, and offers value relative to competitors.
While it trades in
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
Metagenomi Therapeutics (MGX) came out with a quarterly loss of $0.6 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to a loss of $0.63 per share a year ago. These
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
Lineage Cell (LCTX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.01 per share a year ago. These figures are
Samsara Inc. (IOT) Q4 Earnings and Revenues Beat Estimates
Samsara Inc. (IOT) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago. These
Gevo, Inc. (GEVO) Reports Q4 Loss, Tops Revenue Estimates
Gevo, Inc. (GEVO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.09 per share a year ago. These figures are
Traeger (COOK) Q4 Earnings Miss Estimates
Traeger (COOK) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago. These figures
Costco (COST) Q2 Earnings and Revenues Top Estimates
Costco (COST) came out with quarterly earnings of $4.58 per share, beating the Zacks Consensus Estimate of $4.55 per share. This compares to earnings of $4.02 per share a year ago. These figures are
The Cooper Companies (COO) Q1 Earnings Surpass Estimates
The Cooper Companies (COO) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.92 per share a year ago. These
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates
Profound Medical (PROF) came out with a quarterly loss of $0.27 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.2 per share a year ago. These figures are adjusted
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.3 per share a year ago. These
Marvell Technology (MRVL) Q4 Earnings and Revenues Top Estimates
Marvell Technology (MRVL) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.6 per share a year ago. These
GoPro (GPRO) Reports Q4 Loss, Lags Revenue Estimates
GoPro (GPRO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.09 per share a year ago. These figures are adjusted for
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.39 per share a year ago
AudioEye (AEYE) Tops Q4 Earnings and Revenue Estimates
AudioEye (AEYE) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.18 per share a year ago. These figures
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca
Thursday, March 5, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil
Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape
After pulling back sharply from its 52-week high, Rocket Lab (NASDAQ: RKLB) appears to be carving out a meaningful support zone.
Shares are down nearly 30% from their record highs, pressured by
Insiders Are Buying These 3 Energy Stocks
Many investors keep a close eye on insider transactions, as they can often give a decent read surrounding the longer-term picture.
Of course, it’s important to note that insiders have a longer
Cash Flow Kings: 2 Stocks to Hide In, 1 to Avoid
In today’s markets, where macroeconomic concerns, fears centered on AI spending and disruption, inflation, and interest rates weigh on performance, cash flow is king. Companies that produce


